-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
ARS Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from Q1 2020 to Q1 2024.
- ARS Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2024 was $11K, a 45% decline year-over-year.
- ARS Pharmaceuticals, Inc. annual Depreciation for 2023 was $73K, a 115% increase from 2022.
- ARS Pharmaceuticals, Inc. annual Depreciation for 2022 was $34K, a 95.7% decline from 2021.
- ARS Pharmaceuticals, Inc. annual Depreciation for 2021 was $783K, a 22.9% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)